HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 10/15/2012 -- Abbott Laboratories (NYSE:ABT) is engaged in the discovery, development, manufacture, and sale of a range of health care products. Abbott operates in five segments: Proprietary Pharmaceutical Products, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products.Abbott Laboratories (NYSE:ABT) will announce the results of its Q3. Analysts are predicting that the company will report an 8.9% increase in EPS on a 2.7% gain in total revenue when compared to the prior year quarter.This is a name that I believe can be safely purchased prior to the release. The stock has steadily grinded higher for much of the year and sits 23.2% above where it began the year. It's 50-day moving average has steadily pulled away from the 200-day moving average for much of the year. Abbott Laboratories may be close to a Russian buyout. According to government sources, the U.S.-based company wants to acquire its flu-vaccines partner, Petrovax. If the deal goes through, it would be among the three biggest foreign acquisitions in Russian pharma history.
Can ABT Continue To Move Higher? Find Out Here
Unilever NV (NYSE:UN), is a supplier of fast moving consumer goods. The two parent companies, Unilever N.V. (NV) and PLC, together with their group companies, operate as Unilever Group (Unilever). The Company’s products are grouped into four principal areas: Personal Care, Home Care, Foods and Refreshment. The Company operates in three regions: Asia, Africa and Central and Eastern Europe (Asia Africa CEE), the Americas and Western Europe.Unilever NV Commo (NYSE:UN) is +0.38 - +1.05% from the previous close of $36.20. It traded between $36.50 - 36.74 with total traded volume of 502991 shares. Keep a close eye on the UN, as the stock has been showing unusual moves over the past weeks. At Current market price, the UN has recovered +20.17% from its 52-week Low of 30.44 and has Pulled back -0.27% from its 52-week high of 36.68. Unilever is one of the world's leading suppliers of fast moving consumer goods with operations in over 100 countries and sales in 190. Consumers buy 170 billion Unilever packs around the world every year, and our products are used over two billion times a day. We have more than 171,000 employees, and generated annual sales of ?46.5 billion in 2011.
Can UN Extend Massive Gain? Find Out Here
Affymax, Inc. (NASDAQ:AFFY) is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis. Peginesatide is a synthetic peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The Company has a worldwide collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited (Takeda).Affymax, Inc. (NasdaqNM:AFFY) is very active today and traded between $26.50 - 27.08 with total traded volume of 230905 shares. At a current price of 26.929, AFFY is +0.179 - +0.67% from the previous close of $26.75. Moreover, At Current Market Price, AFFY is in the distance of +30.63% from its 50-day Moving Average price of $20.6149 and +71.95% from its 200-day Moving Average price of $15.6606.
Do you think now is a good time to buy or sell AFFY? See AFFY earnings forecast report Here
Arch Capital Group Ltd. (NASDAQ:ACGL) writes insurance and reinsurance on a worldwide basis.ACGL operates in two underwriting segments: insurance and reinsurance. Its insurance operations are conducted in Bermuda, the United States, Europe, Canada, Australia and South Africa. Its insurance operations in Bermuda are conducted through Arch Insurance (Bermuda), a division of Arch Re Bermuda. In the United States, its insurance group's principal insurance subsidiaries are Arch Insurance Company, Arch Excess & Surplus Insurance Company, Arch Specialty Insurance Company, and Arch Indemnity Insurance Company.Arch Capital Grou (NasdaqNM:ACGL) is +0.42 - +0.98% from the previous close of $43.06. It traded between $42.91 - 43.66 with total traded volume of 146465 shares. Keep a close eye on ACGL, as the stock has been showing unusual moves over the past weeks. At Current market price, ACGL has recovered +32.36% from its 52-week Low of 32.85 and has Pulled back -0.02% from its 52-week high of 43.49.Arch Capital Group Ltd (NASDAQ: ACGL) shares gained 1.28% to create a new 52-week high of $43.61. Arch Capital Group is expected to report its Q3 results on October 29, 2012.
Can ACGL Continue To Move Higher? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)